Screening of differentially expressed microRNAs in borderline and malignant gastrointestinal stromal tumors

Chinese Journal of Pathology

Volumn 42, Issue 1, 2013, Pages 20-25

  Shi, Yuan ^a   Wang, Cui Zhong ^a   Hou, Ying Yong ^a   He, De Ming ^a   Xu, Chen ^a   Liu, Ya Lan ^a   Hu, Qin ^a   Akesu, Sujie ^a   Zeng, Hai Ying ^a   Shen, Kun Tang ^a   Tan, Yun Shan ^a   Zhu, Xiong Zeng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Gastrointestinal neoplasms; Microarray analysis; MicroRNAs; Polymerase chain reaction

Indexed keywords

MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN675 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CELL TRANSFORMATION; DOWN REGULATION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84874695370     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2013.01.005     Document Type: Article

References (21)

1. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 1998, 279(5350):577-580. (Pubitemid 28067289)
2. Hou YY, Lu SH, Zhou Y, et al. Stage and histological grade of gastrointestinal stromal tumors based on a new approach are strongly associated with clinical behaviors. Mod Pathol, 2009, 22(4):556-569.
3. Shi Y, Hou YY, Lu SH, et al. Clinical and pathological studies of borderline gastrointestinal stromal tumors. Chin Med J (Engl), 2010, 123(18):2514-2520.
4. Demetri CD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 2002, 347(7):472480.
5. Calin CA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and mil! 16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA, 2002, 99(24):15524-15529. (Pubitemid 35403967)
6. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 2004, 101(9):2999-3004. (Pubitemid 38327724)
7. Bandres E, Cubedo E, Agirre X, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer, 2006, 5:10.
8. Tong AW, Fulgham P, Jay C, et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther, 2009, 16(3):206-216.
9. Tsang WP, Ng EK, Ng SS, et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis, 2010, 31(3):350-358.
10. Schmitz KJ, Helwig J, Bertram S, et al. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours. J Clin Pathol, 2011, 64(6):529-535.
11. Wu DW, Cheng YW, Wang J, et al. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res, 2010, 70(24):10392-10401.
12. Cao C, Zhang Z, Uu W, et al. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer, 2010, 116(1):41-49.
13. Felli N, Fontana L, Pelosi E, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Nad Acad Sci U S A, 2005, 102(50):18081-18086. (Pubitemid 41798505)
14. Fornari F, Gramantieri L, Ferraein M, et al. MiR-221 controls CDKNlC/p57 and CDKNlB/p27 expression in human hepatocellular carcinoma. Oncogene, 2008, 27(43):5651-5661.
15. Pu XX, Huang GL, Guo HQ, et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol, 2010, 25(10):1674-1680.
16. Sredni ST, Bonaldo Mde F, Costa FF, et al. Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst, 2010, 26(3):279-283.
17. Haller F, von Heydebreck A, Zhang JD, et al. Localization-and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32. 31. J Pathol, 2010, 220(1):71-86.
18. Koelz M, Lense J, Wrba F, et al. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors. Int J Oncol, 2011, 38(2):503-511.
19. Fletcher CD, Herman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol, 2002, 10(2):81-89. (Pubitemid 34655094)
20. Miettinen M, Lasota J. Gastrointestinal stromal tumors; review on morphology, molecular pathology, prognosis and differential diagnosis. Arch Pathol Lab Med, 2006, 130(10):1466-1478. (Pubitemid 44520713)
21. Bosnian FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. Lyon: IARC Press, 2010:74-79.